西班牙Agrenvec www.agrenvec.com
西班牙Agrenvec公司是一家专门使用植物生产哺乳动物重组蛋白及抗体的欧洲生物技术企业。采用非转基因植物生产出高度复杂的三维结构的重组蛋白。这些植物源的的抗体，不与其他哺乳动物蛋白的产生交叉反应。Agrenvec的平台技术的基础上使用来自转基因植物病毒的的病毒载体。经过FPLC纯化的蛋白质具有翻译后修饰，至少97%的纯度，100%的活性，并完全排除动物源污染。 Agrenvec还利用这些植物产生的蛋白质生产抗体，因此这些抗体无脊椎动物的背景信号。Agrenvec可以产生蛋白质的量从毫克级到千克级，以满足不同研究客户和商业客户的需要。




Agrenvec is a European biotech specialized in plant production of mammalian recombinant proteins and antibodies for the R&D market.
Agrenvec is focused on development, manufacture and marketing, of products and services for the R&D and Industrial markets. Our Company owns a patented technology platform allowing us a high-throughput production of fully active recombinant proteins with complex 3D structure. Our proteins are 100% animal free and minimum purity of 97%.
This technology is based on the use of vectors derived from plant viruses.
Our production system, compared to transgenic plants, is more efficient and flexible, faster and cheaper. Its scaling up is easier and linear; we obtain from milligrams to kilograms of the protein of interest.
Agrenvec has developed unique purification protocols that combined with our technology platform enable us to produce recombinant proteins very competitively. We have accumulated a deep know-how in industrial production of recombinant proteins and antibodies. After several years of experience we control the whole value chain, from the bench to the final product, thanks to our highly qualified team.
Agrenvec is client-focused, so we adapt to our customer needs in all our projects.
Some of our projects have been co-founded by the Spanish Ministry of Science, and other public organizations, such as Innovation Department of Madrid Regional Government, CDTI, ENISA, Genoma España.